Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathway.

Torr B, Mansour L, Fierheller CT, Hamill M, Nolan J, Bell N, Choi S, Allen S, Muralidharan S, MacMahon S, Clinch Y, Valganon-Petrizan M, Harder H, Garrett A, Evans DG, George A, Jenkins V, Fallowfield L, Legood R, Kemp Z, Manchanda R, Turnbull C

Open source

DOI: 10.1038/s41523-026-01000-4
Published: 2026 Jul 9
Container: NPJ breast cancer
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41523-026-01000-4,
  title = {Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathway.},
  author = {Torr B and Mansour L and Fierheller CT and Hamill M and Nolan J and Bell N and Choi S and Allen S and Muralidharan S and MacMahon S and Clinch Y and Valganon-Petrizan M and Harder H and Garrett A and Evans DG and George A and Jenkins V and Fallowfield L and Legood R and Kemp Z and Manchanda R and Turnbull C},
  year = {2026},
  journal = {NPJ breast cancer},
  doi = {10.1038/s41523-026-01000-4},
  url = {https://doi.org/10.1038/s41523-026-01000-4}
}

RIS

TY  - JOUR
TI  - Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathway.
AU  - Torr B
AU  - Mansour L
AU  - Fierheller CT
AU  - Hamill M
AU  - Nolan J
AU  - Bell N
AU  - Choi S
AU  - Allen S
AU  - Muralidharan S
AU  - MacMahon S
AU  - Clinch Y
AU  - Valganon-Petrizan M
AU  - Harder H
AU  - Garrett A
AU  - Evans DG
AU  - George A
AU  - Jenkins V
AU  - Fallowfield L
AU  - Legood R
AU  - Kemp Z
AU  - Manchanda R
AU  - Turnbull C
PY  - 2026
JO  - NPJ breast cancer
DO  - 10.1038/s41523-026-01000-4
UR  - https://doi.org/10.1038/s41523-026-01000-4
ER  -

APA

B, T., L, M., CT, F., M, H., J, N., N, B., S, C., S, A., S, M., S, M., Y, C., M, V., H, H., A, G., DG, E., A, G., V, J., L, F., R, L., Z, K., R, M., & C, T. (2026). Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathway.. NPJ breast cancer. https://doi.org/10.1038/s41523-026-01000-4

Source records

pubmed · retrieved 2026-09-26T13:15:50.262Z